198 related articles for article (PubMed ID: 20022422)
1. In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic.
Kumar V; Chapple CR; Rosario D; Tophill PR; Chess-Williams R
Eur Urol; 2010 Jun; 57(6):1087-92. PubMed ID: 20022422
[TBL] [Abstract][Full Text] [Related]
2. Enhanced adenosine triphosphate release from the urothelium of patients with painful bladder syndrome: a possible pathophysiological explanation.
Kumar V; Chapple CR; Surprenant AM; Chess-Williams R
J Urol; 2007 Oct; 178(4 Pt 1):1533-6. PubMed ID: 17707056
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis produces significant changes in urinary bladder innervation which are partially reflected in the lower urinary tract functional status-sensory nerve fibers role in detrusor overactivity.
Radziszewski P; Crayton R; Zaborski J; Członkowska A; Borkowski A; Bossowska A; Majewski M
Mult Scler; 2009 Jul; 15(7):860-8. PubMed ID: 19542265
[TBL] [Abstract][Full Text] [Related]
4. Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A.
Smith CP; Vemulakonda VM; Kiss S; Boone TB; Somogyi GT
Neurochem Int; 2005 Sep; 47(4):291-7. PubMed ID: 15970360
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration.
Datta SN; Roosen A; Pullen A; Popat R; Rosenbaum TP; Elneil S; Dasgupta P; Fowler CJ; Apostolidis A
J Urol; 2010 Dec; 184(6):2578-85. PubMed ID: 21030043
[TBL] [Abstract][Full Text] [Related]
6. Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging.
Yoshida M; Miyamae K; Iwashita H; Otani M; Inadome A
Urology; 2004 Mar; 63(3 Suppl 1):17-23. PubMed ID: 15013648
[TBL] [Abstract][Full Text] [Related]
7. Overactive and underactive bladder dysfunction is reflected by alterations in urothelial ATP and NO release.
Munoz A; Smith CP; Boone TB; Somogyi GT
Neurochem Int; 2011 Feb; 58(3):295-300. PubMed ID: 21145365
[TBL] [Abstract][Full Text] [Related]
8. Does adenosine triphosphate released into voided urodynamic fluid contribute to urgency signaling in women with bladder dysfunction?
Cheng Y; Mansfield KJ; Allen W; Walsh CA; Burcher E; Moore KH
J Urol; 2010 Mar; 183(3):1082-6. PubMed ID: 20092837
[TBL] [Abstract][Full Text] [Related]
9. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder.
Andersson KE; Gratzke C; Hedlund P
BJU Int; 2010 Oct; 106(8):1114-27. PubMed ID: 21156013
[TBL] [Abstract][Full Text] [Related]
10. Treatment-resistant detrusor overactivity--underlying pharmacology and potential mechanisms.
Andersson KE
Int J Clin Pract Suppl; 2006 Dec; (151):8-16. PubMed ID: 17169005
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of Connexin 43 (Cx43) in human bladder tissue in patients with idiopathic detrusor overactivity.
Kuhn A; Stadlmayr W; Monga A; Cameron I; Anthony F
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):83-6. PubMed ID: 18687515
[TBL] [Abstract][Full Text] [Related]
12. Increased transient receptor potential vanilloid type 1 (TRPV1) signaling in idiopathic overactive bladder urothelial cells.
Li M; Sun Y; Simard JM; Chai TC
Neurourol Urodyn; 2011 Apr; 30(4):606-11. PubMed ID: 21351130
[TBL] [Abstract][Full Text] [Related]
13. Cadherin-11 up-regulation in overactive bladder suburothelial myofibroblasts.
Roosen A; Apostolidis A; Elneil S; Khan S; Panicker J; Brandner S; Fowler CJ; Kessler TM
J Urol; 2009 Jul; 182(1):190-5. PubMed ID: 19450843
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor release from the urothelium increases via activation of bladder C-fiber in rats with cerebral infarction.
Yokokawa R; Akino H; Ito H; Zha X; Yokoyama O
Neurourol Urodyn; 2017 Aug; 36(6):1448-1455. PubMed ID: 27676696
[TBL] [Abstract][Full Text] [Related]
15. Role of urothelial nerve growth factor in human bladder function.
Birder LA; Wolf-Johnston A; Griffiths D; Resnick NM
Neurourol Urodyn; 2007; 26(3):405-9. PubMed ID: 17266135
[TBL] [Abstract][Full Text] [Related]
16. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin.
Apostolidis A; Brady CM; Yiangou Y; Davis J; Fowler CJ; Anand P
Urology; 2005 Feb; 65(2):400-5. PubMed ID: 15708075
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.
Peyronnet B; Mironska E; Chapple C; Cardozo L; Oelke M; Dmochowski R; Amarenco G; Gamé X; Kirby R; Van Der Aa F; Cornu JN
Eur Urol; 2019 Jun; 75(6):988-1000. PubMed ID: 30922690
[TBL] [Abstract][Full Text] [Related]
18. How does the urothelium affect bladder function in health and disease? ICI-RS 2011.
Birder LA; Ruggieri M; Takeda M; van Koeveringe G; Veltkamp S; Korstanje C; Parsons B; Fry CH
Neurourol Urodyn; 2012 Mar; 31(3):293-9. PubMed ID: 22275289
[TBL] [Abstract][Full Text] [Related]
19. Alteration in contractile responses in human detrusor smooth muscle from obstructed bladders with overactivity.
Kosan M; Tul M; Ozturk B; Hafez G; Inal G; Cetinkaya M
Urol Int; 2008; 80(2):193-200. PubMed ID: 18362492
[TBL] [Abstract][Full Text] [Related]
20. Altered urothelial ATP signaling in a major subset of human overactive bladder patients with pyuria.
Contreras-Sanz A; Krska L; Balachandran AA; Curtiss NL; Khasriya R; Kelley S; Strutt M; Gill HS; Taylor KM; Mansfield KJ; Wu C; Peppiatt-Wildman CM; Malone-Lee J; Duckett J; Wildman SS
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F805-F816. PubMed ID: 27358056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
